{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:04:36Z","timestamp":1761487476881},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T00:00:00Z","timestamp":1123804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9,22]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Ivermectin treatment will effectively diminish microfilariae (Mf) of Onchocerca volvulus in the skin of patients, but therapy is associated with adverse host inflammatory responses. To investigate the association of proinflammatory chemokines with the intensity of infection and clinical adverse reactions, chemokine serum levels were measured in patients following ivermectin treatment (100\u2003\u00b5g\/kg, 150\u2003\u00b5g\/kg or 200\u2003\u00b5g\/kg) or placebo. The density of O. volvulus Mf per mg skin decreased by 85%, 97%, 97% and 90% at day 3, at month 3, month 6 and at 1\u2003year post-ivermectin. The cutaneous T cell-attracting chemokine (CTACK\/CCL27) was found highly elevated in onchocerciasis patients compared to infection-free European controls (P\u2003=\u20030\u00b70004) and it did not change following ivermectin or placebo to 1\u2003year post-therapy. The chemokine RANTES\/CCL5 (regulated on activated and normally T cell-expressed) was similarly high in onchocerciasis patients and infection-free European controls; the RANTES\/CCL5 levels did not change following treatment until 6\u2003months post-therapy but were slightly elevated at 1\u2003year post-therapy (P\u2003&amp;lt;\u20030\u00b702). In contrast, the Th2-type chemoattractants, thymus and activation regulated chemokine (TARC\/CCL17) and macrophage-derived chemokine (MDC\/CCL22), were activated at 3\u2003days post-ivermectin (P\u2003&amp;lt;\u20030\u00b70001) to return to pretreatment or lower levels thereafter. The Th1-type chemoattractants, macrophage inflammatory protein (MIP)-1\u03b1\/CCL3 and MIP-1\u03b2\/CCL4 were low before ivermectin treatment, but following clearance of microfilariae of O. volvulus their levels increased from 6\u2003months post-therapy onwards (for both at 12\u2003months post-therapy, P\u2003&amp;lt;\u20030\u00b70001). The adverse reaction scores (RS) in treated patients increased significantly on day 3 (P\u2003&amp;lt;\u20030\u00b702) while it remained unchanged in those who received placebo (P\u2003=\u20030\u00b722); RS interacted with the microfilarial density (P\u2003=\u20030\u00b701), but not with the dose of ivermectin or with the serum levels of MIP-1\u03b1\/CCL3, MIP-1\u03b2\/CCL4, TARC\/CCL17, MDC\/CCL22 and CTACK\/CCL27. Our observations suggest that following ivermectin, macrophages as well as memory Th2-type lymphocytes and B cells, attracted and activated by MDC\/CCL22, TARC\/CCL17 and CTACK\/CCL27, may contribute to dermal immune responses and O. volvulus Mf killing and clearance. The transient changes of TARC\/CCL17 and MDC\/CCL22 were not associated with clinical adverse responses, and the later rise of MIP-1\u03b1\/CCL3 and MIP-1\u03b2\/CCL4 showed a reactivation of Type 1 immune responses associated with persistent low levels of O. volvulus microfilariae and an expiring O. volvulus infection.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2005.02910.x","type":"journal-article","created":{"date-parts":[[2005,10,18]],"date-time":"2005-10-18T08:52:47Z","timestamp":1129625567000},"page":"318-326","source":"Crossref","is-referenced-by-count":19,"title":["Chemokines in onchocerciasis patients after a single dose of ivermectin"],"prefix":"10.1093","volume":"142","author":[{"given":"J","family":"Fendt","sequence":"first","affiliation":[{"name":"Institute for Tropical Medicine, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D M","family":"Hamm","sequence":"additional","affiliation":[{"name":"Institute for Tropical Medicine, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Banla","sequence":"additional","affiliation":[{"name":"Facult\u00e9 Mixte de M\u00e9dicine et de Pharmacie, Universit\u00e9 de Lom\u00e9, Togo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Schulz-Key","sequence":"additional","affiliation":[{"name":"Institute for Tropical Medicine, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Wolf","sequence":"additional","affiliation":[{"name":"Institute for Tropical Medicine, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Helling-Giese","sequence":"additional","affiliation":[{"name":"Institute for Tropical Medicine, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Heuschkel","sequence":"additional","affiliation":[{"name":"Institute for Tropical Medicine, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P T","family":"Soboslay","sequence":"additional","affiliation":[{"name":"Institute for Tropical Medicine, University of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,8,12]]},"reference":[{"key":"2022010711174770600_b1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1056\/NEJM198507183130301","article-title":"Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis","volume":"313","author":"Greene","year":"1985","journal-title":"N Engl J Med"},{"key":"2022010711174770600_b2","first-page":"19","article-title":"Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects","volume":"39","author":"Albiez","year":"1988","journal-title":"Trop Med Parasitol"},{"key":"2022010711174770600_b3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/infdis\/156.3.463","article-title":"Controlled trial and dose-finding study of ivermectin for treatment of onchocerciasis","volume":"156","author":"White","year":"1987","journal-title":"J Infect Dis"},{"key":"2022010711174770600_b4","first-page":"8","article-title":"Ivermectin effect on microfilaria of Onchocerca volvulus after a single oral dose in humans","volume":"38","author":"Soboslay","year":"1987","journal-title":"Trop Med Parasitol"},{"key":"2022010711174770600_b5","first-page":"299","article-title":"Dynamics of microfilariae of Onchocerca volvulus over the first 72 hours after treatment with ivermectin","volume":"40","author":"Richards","year":"1989","journal-title":"Trop Med Parasitol"},{"key":"2022010711174770600_b6","first-page":"361","article-title":"Immunohistological and electron microscopic studies of microfilariae in skin and lymph nodes from onchocerciasis patients after ivermectin treatment","volume":"42","author":"Darge","year":"1991","journal-title":"Trop Med Parasitol"},{"key":"2022010711174770600_b7","first-page":"87","article-title":"Lymph nodes of onchocerciasis patients after treatment with ivermectin: reaction of eosinophil granulocytes and their cationic granule proteins","volume":"45","author":"Wildenburg","year":"1994","journal-title":"Trop Med Parasitol"},{"key":"2022010711174770600_b8","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1590\/S0100-879X2003001100002","article-title":"The role of chemokines and chemokine receptors in eosinophil activation during inflammatory allergic reactions","volume":"36","author":"Oliveira","year":"2003","journal-title":"Braz J Med Biol Res"},{"key":"2022010711174770600_b9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2796.2001.00867.x","article-title":"Chemokines in pathology and medicine","volume":"250","author":"Baggiolini","year":"2001","journal-title":"J Intern Med"},{"key":"2022010711174770600_b10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1365-2249.1996.d01-868.x","article-title":"RANTES in onchocerciasis: changes with ivermectin treatment","volume":"106","author":"Cooper","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"2022010711174770600_b11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/clim.1999.4829","article-title":"Eotaxin and RANTES expression by the dermal endothelium is associated with eosinophil infiltration after ivermectin treatment of onchocerciasis","volume":"95","author":"Cooper","year":"2000","journal-title":"Clin Immunol"},{"key":"2022010711174770600_b12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2249.2000.01163.x","article-title":"The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC)","volume":"119","author":"Gasim","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"2022010711174770600_b13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2249.1994.tb06548.x","article-title":"Ivermectin-facilitated immunity in onchocerciasis. Activation of parasite-specific Th1 type responses with subclinical Onchocerca volvulus infection","volume":"96","author":"Soboslay","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"2022010711174770600_b14","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/517832","article-title":"Antigen-specific proliferation and interferon-gamma and interleukin-5 production are down-regulated during Schistosoma haematobium infection","volume":"177","author":"Grogan","year":"1998","journal-title":"J Infect Dis"},{"key":"2022010711174770600_b15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1086\/517456","article-title":"Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection","volume":"178","author":"Mutapi","year":"1998","journal-title":"J Infect Dis"},{"key":"2022010711174770600_b16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jaci.2004.03.024","article-title":"Mechanisms of immunotherapy","volume":"113","author":"Till","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"2022010711174770600_b17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.all.0000136753.35948.c0","article-title":"Mechanisms of immunotherapy: IgG revisited","volume":"4","author":"Wachholz","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2022010711174770600_b18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1074-7613(01)00261-8","article-title":"Chemokines and the tissue-specific migration of lymphocytes","volume":"16","author":"Kunkel","year":"2002","journal-title":"Immunity"},{"key":"2022010711174770600_b19","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.4049\/jimmunol.157.8.3598","article-title":"Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response","volume":"157","author":"Schrum","year":"1996","journal-title":"J Immunol"},{"key":"2022010711174770600_b20","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jaci.2003.08.049","article-title":"Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis","volume":"112","author":"Nomura","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"2022010711174770600_b21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jdermsci.2004.03.001","article-title":"Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis","volume":"35","author":"Fujii","year":"2004","journal-title":"J Dermatol Sci"},{"key":"2022010711174770600_b22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1034\/j.1398-9995.2003.00149.x","article-title":"Accumulation of CCR4-expressing CD4+ T cells and high concentration of its ligands (TARC and MDC) in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia","volume":"58","author":"Katoh","year":"2003","journal-title":"Allergy"},{"key":"2022010711174770600_b23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2249.2002.01985.x","article-title":"Elevated levels of thymus and activation-regulated chemokine (TARC) in pleural effusion samples from patients infested with Paragonimus westermani","volume":"130","author":"Matsumoto","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"2022010711174770600_b24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jdermsci.2004.09.001","article-title":"Effect of an antiallergic drug (olopatadine hydrochloride) on TARC\/CCL17 and MDC\/CCL22 production by PBMCs from patients with atopic dermatitis","volume":"36","author":"Furukawa","year":"2004","journal-title":"J Dermatol Sci"},{"key":"2022010711174770600_b25","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0002-9440(10)63381-0","article-title":"Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice","volume":"165","author":"Jakubzick","year":"2004","journal-title":"Am J Pathol"},{"key":"2022010711174770600_b26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jaci.2004.03.048","article-title":"Association between TARC C-431T and atopy and asthma in children","volume":"114","author":"Leung","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"2022010711174770600_b27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jaci.2003.12.007","article-title":"Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis","volume":"113","author":"Hijnen","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"2022010711174770600_b28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jdermsci.2004.01.001","article-title":"Both Th2 and Th1 chemokines (TARC\/CCL17, MDC\/CCL22, and Mig\/CXCL9) are elevated in sera from patients with atopic dermatitis","volume":"34","author":"Shimada","year":"2004","journal-title":"J Dermatol Sci"},{"key":"2022010711174770600_b29","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.4049\/jimmunol.169.6.3284","article-title":"An enteric helminth infection protects against an allergic response to dietary antigen","volume":"169","author":"Bashir","year":"2002","journal-title":"J Immunol"},{"key":"2022010711174770600_b30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.296.5567.490","article-title":"Allergy, parasites, and the hygiene hypothesis","volume":"296","author":"Yazdanbakhsh","year":"2002","journal-title":"Science"},{"key":"2022010711174770600_b31","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1046\/j.1365-2133.2003.05403.x","article-title":"Dirt, worms and atopic dermatitis","volume":"148","author":"Flohr","year":"2003","journal-title":"Br J Dermatol"},{"key":"2022010711174770600_b32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1385\/CRIAI:26:1:35","article-title":"Regulation of allergy and autoimmunity in helminth infection","volume":"26","author":"Wilson","year":"2004","journal-title":"Clin Rev Allergy Immunol"},{"key":"2022010711174770600_b33","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.4049\/jimmunol.164.7.3465","article-title":"Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK\/ALP\/ILC)","volume":"164","author":"Homey","year":"2000","journal-title":"J Immunol"},{"key":"2022010711174770600_b34","doi-asserted-by":"crossref","first-page":"14470","DOI":"10.1073\/pnas.96.25.14470","article-title":"CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells","volume":"96","author":"Morales","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010711174770600_b35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2230.2004.01501.x","article-title":"Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children","volume":"29","author":"Hon","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"2022010711174770600_b36","first-page":"1179","article-title":"Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 beta expression in Kawasaki disease","volume":"24","author":"Wong","year":"1997","journal-title":"J Rheumatol"},{"key":"2022010711174770600_b37","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1086\/345370","article-title":"Plasma concentrations and role of macrophage inflammatory protein-1alpha during chronic Schistosoma mansoni infection in humans","volume":"186","author":"Falcao","year":"2002","journal-title":"J Infect Dis"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2005.02910.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/142\/2\/318\/42078438\/j.1365-2249.2005.02910.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/142\/2\/318\/42078438\/j.1365-2249.2005.02910.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T03:52:00Z","timestamp":1683258720000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/142\/2\/318\/6440389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,12]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,8,12]]},"published-print":{"date-parts":[[2005,9,22]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2005.02910.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,11]]},"published":{"date-parts":[[2005,8,12]]}}}